The advantages of clinical trials
Andrea B. Apolo
Panitumumab data presented at ESMO 2016: depth of response and selecting the right patients
Phase 1b trial of CRS-207 with chemotherapy for malignant pleural mesothelioma
Tremelimumab and durvalumab therapy in lung cancer
What can histology tell us to ProtecT against prostate cancer?